US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
AMEX
AgeX Therapeutics Inc (AGE)
AgeX Therapeutics Inc (AGE) ニュース

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AGE

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/23	06 : 27	GlobeNewswire Inc.	AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results	AMEX:AGE	AgeX Therapeutics Inc
2024/03/08	06 : 49	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	AMEX:AGE	AgeX Therapeutics Inc
2024/03/08	06 : 47	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2024/03/07	21 : 47	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/02/15	06 : 01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/02/14	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:AGE	AgeX Therapeutics Inc
2024/02/07	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2024/02/05	21 : 19	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2024/01/19	07 : 29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:AGE	AgeX Therapeutics Inc
2024/01/18	06 : 19	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/01/16	23 : 11	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/01/12	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2024/01/10	06 : 16	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2024/01/06	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/12/29	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/12/19	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/12/14	07 : 11	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2023/12/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/12/02	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/11/18	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/11/17	06 : 01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2023/11/15	23 : 38	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:AGE	AgeX Therapeutics Inc
2023/11/15	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/11/15	06 : 05	Business Wire	AgeX Therapeutics Reports Third Quarter 2023 Financial Results	AMEX:AGE	AgeX Therapeutics Inc
2023/11/08	06 : 06	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:AGE	AgeX Therapeutics Inc
2023/11/08	06 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:AGE	AgeX Therapeutics Inc
2023/11/07	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc
2023/11/02	05 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:AGE	AgeX Therapeutics Inc
2023/10/07	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AGE	AgeX Therapeutics Inc

Showing the most relevant articles for your search:AMEX:AGE

1 2 3 4 5 6 7 8 9 次へ >>

BNP Paribas (QX)

American Express

Health Care Select Sector

Deutsche Telekom (QX)

Energy Select Sector SPDR

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約